{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:17:50Z","timestamp":1792271870228,"version":"4.4.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.lfs.2018.12.018","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T03:36:53Z","timestamp":1544585813000},"page":"112-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":300,"special_numbering":"C","title":["Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision"],"prefix":"10.1016","volume":"218","author":[{"given":"Ashif","family":"Iqubal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Kashif","family":"Iqubal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Asif","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mansoor","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ehtaishamul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.12.018_bb0005","series-title":"Cancer Statistics in","author":"W.H. Organisation","year":"2018"},{"key":"10.1016\/j.lfs.2018.12.018_bb0010","unstructured":"N.H. Institute, Cancer Statistics, in, 2018, 27 April, pp. 15 july."},{"key":"10.1016\/j.lfs.2018.12.018_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2459\/JCM.0000000000000667","article-title":"Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention","volume":"19","author":"Dessalvi","year":"2018","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2018.04.009","article-title":"Anticancer drug-induced cardiac rhythm disorders: current knowledge and basic underlying mechanisms","volume":"189","author":"Alexandre","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.12.018_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002620050498","article-title":"Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer","volume":"47","author":"Bass","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2018.12.018_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1261270","article-title":"Ferulic acid against cyclophosphamide-induced heart toxicity in mice by inhibiting NF-\u03baB pathway","volume":"2016","author":"Song","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/2156587218757649","article-title":"Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats","volume":"23","author":"Omole","year":"2018","journal-title":"J. Evid. Based Integr. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2018.02.005","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide using non-first-degree related donors","volume":"24","author":"Elmariah","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0045","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jama.296.12.1518","article-title":"An anniversary for cancer chemotherapy","volume":"296","author":"Hirsch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2018.12.018_bb0050","first-page":"169","article-title":"Bicentennial: the birth of chemotherapy at Yale: bicentennial lecture series: surgery grand round","volume":"84","author":"Christakis","year":"2011","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0360-3016(85)90254-8","article-title":"Nitrogen mustard: the origin of chemotherapy for cancer","volume":"11","author":"Einhorn","year":"1985","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13104-017-2726-2","article-title":"Role of metabolites of cyclophosphamide in cardiotoxicity","volume":"10","author":"Kurauchi","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.lfs.2018.12.018_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2015.12.007","article-title":"Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma","volume":"55","author":"Veal","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000073353","article-title":"Ifosfamide and cyclophosphamide: effects on immunosurveillance","volume":"65","author":"Binotto","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.lfs.2018.12.018_bb0075","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.intimp.2011.04.011","article-title":"Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb\/c mice","volume":"11","author":"Huyan","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","article-title":"Cardiotoxicity associated with high-dose cyclophosphamide therapy","volume":"141","author":"Gottdiener","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2018.12.018_bb0090","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1259\/bjr.73.874.11271907","article-title":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy","volume":"73","author":"Birchall","year":"2000","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0095","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2169\/internalmedicine.52.0347","article-title":"Cyclophosphamide-induced cardiotoxicity with a prolonged clinical course diagnosed on an endomyocardial biopsy","volume":"52","author":"Kusumoto","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4172\/pharmaceutical-sciences.1000340","article-title":"Immunomodulatory effects of gallic acid against cyclophosphamide-and cisplatin-induced immunosuppression in Swiss albino mice","volume":"80","author":"Shruthi","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijbiomac.2018.04.178","article-title":"Ameliorative effects of Antrodia cinnamomea polysaccharides against cyclophosphamide-induced immunosuppression related to Nrf2\/HO-1 signaling in BALB\/c mice","volume":"116","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2018.12.018_bb0115","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.1200274","article-title":"Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma","volume":"189","author":"Kodumudi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12012-016-9396-5","article-title":"Acrolein can cause cardiovascular disease: a review","volume":"17","author":"Henning","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0125","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.yjmcc.2008.03.020","article-title":"Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKC\u03b5 signaling and cardioprotection","volume":"44","author":"Wang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0130","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/tx3000818","article-title":"Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation\u2013modification of proteins in vitro: identification of N \u03c4-(3-propanal) histidine as the major adduct","volume":"25","author":"Maeshima","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0135","first-page":"H2050","article-title":"Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy","volume":"301","author":"Ismahil","year":"2011","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0145","series-title":"Advances in Molecular Toxicology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1872-0854(10)04001-4","article-title":"Invited review: acrolein and the lung: chemical, molecular, and pathological aspects","author":"Burcham","year":"2010"},{"key":"10.1016\/j.lfs.2018.12.018_bb0150","doi-asserted-by":"crossref","first-page":"e000934","DOI":"10.1161\/JAHA.114.000934","article-title":"Acrolein exposure is associated with increased cardiovascular disease risk","volume":"3","author":"DeJarnett","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2018.12.018_bb0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2013.06.024","article-title":"The effects of acetaldehyde and acrolein on muscle catabolism in C2 myotubes","volume":"65","author":"Rom","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.109.194928","article-title":"Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo","volume":"105","author":"Willis","year":"2009","journal-title":"Circ. Res"},{"key":"10.1016\/j.lfs.2018.12.018_bb0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/taap.1999.8879","article-title":"Cellular mechanisms of acrolein-induced alteration in calcium signaling in airway smooth muscle","volume":"164","author":"Hyvelin","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10741-015-9502-y","article-title":"Chemotherapy-induced cardiomyopathy","volume":"20","author":"Higgins","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2018.12.018_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2350\/13-04-1324-CR.1","article-title":"Cyclophosphamide-associated cardiotoxicity in a child after stem cell transplantation for \u03b2-thalassemia major: case report and review of the literature","volume":"17","author":"Meserve","year":"2014","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1752-1947-8-252","article-title":"Cardiotoxicity following cyclophosphamide therapy: a case report","volume":"8","author":"Atalay","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/CS20120620","article-title":"Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury","volume":"126","author":"Sandhu","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.15264\/cpho.2018.25.1.71","article-title":"A case of successfully treated severe heart failure due to cyclophosphamide induced cardiomyopathy","volume":"25","author":"Park","year":"2018","journal-title":"Clin. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0195","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","article-title":"Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant","volume":"12","author":"Hertenstein","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12185-008-0112-5","article-title":"Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation","volume":"88","author":"Zver","year":"2008","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0205","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2018.12.018_bb0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mpo.2950090502","article-title":"Cardiac changes with cyclophosphamide","volume":"9","author":"Steinherz","year":"1981","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2018.12.018_bb0220","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y","article-title":"Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature","volume":"43","author":"Mills","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jjcc.2009.01.006","article-title":"Fulminant fatal cardiotoxicity following cyclophosphamide therapy","volume":"54","author":"Katayama","year":"2009","journal-title":"J. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0230","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J. Invest. Med. High Impact Case Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0240","series-title":"Transplantation Proceedings","first-page":"400","article-title":"Marrow transplanation in man following cyclophosphamide","author":"Santos","year":"1971"},{"key":"10.1016\/j.lfs.2018.12.018_bb0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2169\/internalmedicine.44.120","article-title":"Cyclophosphamide-induced cardiomyopathy in a patient with seminoma and a history of mediastinal irradiation","volume":"44","author":"Kamezaki","year":"2005","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bmt.1703132","article-title":"Serum cardiac troponin I levels and ECG\/Echo monitoring in breast cancer patients undergoing high-dose (7\u202fg\/m 2) cyclophosphamide","volume":"28","author":"Morandi","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/pm.pm_469_17","article-title":"Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear factor-like 2 activation","volume":"14","author":"Sharma","year":"2018","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.lfs.2018.12.018_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2018.10.034","article-title":"Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-\u03b1","volume":"842","author":"Khan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0265","first-page":"16","article-title":"Clinical updates on drug-induced cardiotoxicity","volume":"9","author":"Iqubal","year":"2018","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0270","first-page":"1095","article-title":"The heartaches of cancer therapy: acute and late cardiotoxicity in cancer survivors","volume":"30","author":"Chokshi","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.lfs.2018.12.018_bb0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2018.12.018_bb0280","series-title":"Anti-cancer Treatments and Cardiotoxicity","first-page":"35","article-title":"Cardiotoxicity of oncologic treatments: is there a uniform definition?","author":"Scherrer-Crosbie","year":"2016"},{"key":"10.1016\/j.lfs.2018.12.018_bb0285","first-page":"59","article-title":"Chemotherapy-induced cardiotoxicity","volume":"8","author":"Florescu","year":"2013","journal-title":"Maedica"},{"key":"10.1016\/j.lfs.2018.12.018_bb0290","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0295","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0300","series-title":"Advances in Clinical Chemistry","first-page":"33","article-title":"Current applications of cardiac troponin T for the diagnosis of myocardial damage","author":"Vasatova","year":"2013"},{"key":"10.1016\/j.lfs.2018.12.018_bb0305","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","article-title":"Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study","volume":"356","author":"Traynor","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2018.12.018_bb0310","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.10752","article-title":"High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus","volume":"48","author":"Petri","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2018.12.018_bb0315","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0198-8859(02)00414-7","article-title":"High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review","volume":"63","author":"Toes","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ana.10400","article-title":"Treatment of refractory myasthenia: \u201crebooting\u201d with high-dose cyclophosphamide","volume":"53","author":"Drachman","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0325","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneurol.65.8.noc80042","article-title":"Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis","volume":"65","author":"Krishnan","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0330","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2002-01-0087","article-title":"High-dose cyclophosphamide for refractory autoimmune hemolytic anemia","volume":"100","author":"Moyo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2018.12.018_bb0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4048\/jbc.2017.20.4.347","article-title":"Cyclophosphamide, methotrexate, and 5-fluorouracil as palliative treatment for heavily pretreated patients with metastatic breast cancer: a multicenter retrospective analysis","volume":"20","author":"Park","year":"2017","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jcpt.12124","article-title":"Incidence and risk-factors of CHOP\/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma","volume":"39","author":"Limat","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.lfs.2018.12.018_bb0345","series-title":"Am Soc Hematology","article-title":"Intermediate dose methotrexate improves overall survival and progression-free survival of patients with diffuse large B cell lymphoma treated with the R-CHOP or CHOP regimen","author":"Dann","year":"2015"},{"key":"10.1016\/j.lfs.2018.12.018_bb0350","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography\/computed tomography scan after two ABVD cycles: long-term results of the GITIL\/FIL HD 0607 trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0355","first-page":"1","article-title":"EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma","author":"Toriyama","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0360","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/cncr.24221","volume":"115","author":"Kyle","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0365","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/0277-5379(91)90447-L","article-title":"M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder: the French federation of Cancer centers experience","volume":"27","author":"Boutan-Laroze","year":"1991","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0370","unstructured":"I.W.G. on the Evaluation, CYCLOPHOSPHAMIDE, (2012)."},{"key":"10.1016\/j.lfs.2018.12.018_bb0375","doi-asserted-by":"crossref","first-page":"e006915","DOI":"10.1161\/JAHA.117.006915","article-title":"Cardiotoxicity from human epidermal growth factor Receptor-2 (HER 2) targeted therapies","volume":"6","author":"Florido","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2018.12.018_bb0380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1470-2045(02)00676-9","article-title":"Trastuzumab: hopes and realities","volume":"3","author":"Leyland-Jones","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0385","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.122249299","article-title":"Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy","volume":"99","author":"\u00d6zcelik","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0390","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0395","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.critrevonc.2014.12.008","article-title":"Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"94","author":"Ghatalia","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0400","first-page":"251","article-title":"Prevention and management of cardiotoxicity from antineoplastic therapy","volume":"2","author":"Chanan-Khan","year":"2004","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0405","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14740338.2.1.59","article-title":"Cardiotoxic effects of anthracycline-taxane combinations","volume":"2","author":"Perotti","year":"2003","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.lfs.2018.12.018_bb0410","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1158\/1078-0432.CCR-05-0539","article-title":"Feasibility and tolerability of sequential doxorubicin\/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy","volume":"11","author":"Gianni","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0415","article-title":"23 a patient with breast cancer experiencing cardiac toxicity on chemotherapy, problem solving in older cancer patients: a case study based reference and learning","volume":"239","author":"Chowdhury","year":"2016","journal-title":"Resource"},{"key":"10.1016\/j.lfs.2018.12.018_bb0420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19930115)71:2<493::AID-CNCR2820710235>3.0.CO;2-C","article-title":"The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy","volume":"71","author":"Robben","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/870640","article-title":"Decreased cortisol and pain in breast cancer: biofield therapy potential","volume":"2015","author":"Running","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0430","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/art.11081","article-title":"Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis","volume":"48","author":"Apras","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2018.12.018_bb0435","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(91)90241-P","article-title":"Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity","volume":"64","author":"Boyle","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.12.018_bb0440","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/NAN.0000000000000285","article-title":"Cancer and the broken heart: complications and implications of therapy-related cardiotoxicity","volume":"41","author":"Boyle","year":"2018","journal-title":"J. Infus. Nurs."},{"key":"10.1016\/j.lfs.2018.12.018_bb0445","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0450","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fphar.2013.00019","article-title":"Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy","volume":"4","author":"Sheppard","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0455","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/1097-0142(19900501)65:9<1913::AID-CNCR2820650907>3.0.CO;2-T","article-title":"Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood","volume":"65","author":"M\u00e4kinen","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2018.12.018_bb0460","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1702394","article-title":"Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer","volume":"25","author":"Klein","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0465","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2018.12.018_bb0470","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients","volume":"13","author":"Jensen","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0475","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bmt.2017.188","article-title":"Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening","volume":"52","author":"Martin","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0480","article-title":"The cardiotoxicity of chemotherapy: new prospects for an old problem","volume":"40","author":"Miolo","year":"2006","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0485","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0046-8177(76)80004-4","article-title":"Cardiac pathologic findings in patients treated with bone marrow transplantation","volume":"7","author":"Buja","year":"1976","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.44.89","article-title":"Clinical significance of cyclophosphamide-induced cardiotoxicity","volume":"44","author":"Taniguchi","year":"2005","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0495","first-page":"160","article-title":"Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines","volume":"30","author":"Pudil","year":"2008","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0500","doi-asserted-by":"crossref","first-page":"e0131394","DOI":"10.1371\/journal.pone.0131394","article-title":"Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention","volume":"10","author":"Nishikawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.12.018_bb0505","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0510","first-page":"4229","article-title":"Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes","volume":"57","author":"Ren","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0515","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/RES.0000000000000097","article-title":"Assessing cardiac metabolism: a scientific statement from the American Heart Association","volume":"118","author":"Taegtmeyer","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0520","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10557-006-0634-0","article-title":"Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease","volume":"20","author":"Lopaschuk","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2018.12.018_bb0525","first-page":"275","article-title":"Protection by L-carnitine against the inhibition of gene expression of heart fatty acid binding protein by chronic administration of doxorubicin","volume":"12","author":"Sayed-Ahmed","year":"2000","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"10.1016\/j.lfs.2018.12.018_bb0530","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/cipms-2017-0014","article-title":"Prospective of ischemic stroke biomarkers","volume":"30","author":"Szewczak","year":"2017","journal-title":"Curr. Issues Pharm. Med. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0535","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2018.12.018_bb0540","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine--metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2018.12.018_bb0545","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0550","article-title":"Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity","volume":"1","author":"ElGhandour","year":"2009","journal-title":"Hematol. Rev."},{"key":"10.1016\/j.lfs.2018.12.018_bb0555","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bcpt.12679","article-title":"The effects of l-carnitine against cyclophosphamide-induced injuries in mouse testis","volume":"120","author":"Cao","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000298822","article-title":"Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats","volume":"56","author":"Fatani","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.lfs.2018.12.018_bb0565","series-title":"Isoforms of Acetyl-CoA Carboxylase: Structures, Regulatory Properties and Metabolic Functions","author":"Brownsey","year":"1997"},{"key":"10.1016\/j.lfs.2018.12.018_bb0570","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0575","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1113\/JP273609","article-title":"Mitochondrial energetics and calcium coupling in the heart","volume":"595","author":"Kohlhaas","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0580","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11897-017-0347-7","article-title":"Targeting mitochondrial calcium handling and reactive oxygen species in heart failure","volume":"14","author":"Dietl","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0585","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0253-7613.106434","article-title":"Cardioprotective effect of saraca indica against cyclophosphamide induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study","volume":"45","author":"Swamy","year":"2013","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.lfs.2018.12.018_bb0590","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11033-011-0763-9","article-title":"The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in Sertoli cells","volume":"39","author":"Liu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181086","article-title":"Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects","volume":"12","author":"Crouch","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.12.018_bb0600","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1360-1385(02)02312-9","article-title":"Oxidative stress, antioxidants and stress tolerance","volume":"7","author":"Mittler","year":"2002","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00395-015-0468-7","article-title":"Loss of dihydrolipoyl succinyltransferase (DLST) leads to reduced resting heart rate in the zebrafish","volume":"110","author":"Ke\u00dfler","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0610","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbt.20369","article-title":"Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats","volume":"25","author":"Nagi","year":"2011","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0615","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.nut.2009.01.004","article-title":"Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione","volume":"25","author":"Todorova","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2018.12.018_bb0620","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/jphp.12016","article-title":"Crocin, a dietary colorant mitigates cyclophosphamide-induced organ toxicity by modulating antioxidant status and inflammatory cytokines","volume":"65","author":"Jnaneshwari","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0625","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.etap.2015.07.013","article-title":"Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats","volume":"40","author":"Mansour","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0630","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4161\/oxim.3.5.13107","article-title":"Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues","volume":"3","author":"Asiri","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2018.12.018_bb0635","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1191\/0960327105ht530oa","article-title":"Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress","volume":"24","author":"Sudharsan","year":"2005","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0640","doi-asserted-by":"crossref","first-page":"e0127813","DOI":"10.1371\/journal.pone.0127813","article-title":"Blueberry anthocyanins-enriched extracts attenuate cyclophosphamide-induced cardiac injury","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.12.018_bb0645","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2017.05.006","article-title":"Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality","volume":"110","author":"Jeelani","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0650","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.freeradbiomed.2016.10.466","article-title":"A potential role of Nox1 isoform of NADPH oxidase in the development of nonalcoholic steatohepatitis","volume":"100","author":"Matsumoto","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0655","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/newbio233250b0","article-title":"Formation of the cytotoxic aldehyde acrolein during in vitro degradation of cyclophosphamide","volume":"233","author":"Alarcon","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0660","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0665","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12012-016-9361-3","article-title":"Omega-3 fatty acid protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo","volume":"17","author":"Varghese","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0670","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-079X.2010.00756.x","article-title":"Effect of melatonin on the expression of Nrf2 and NF-\u03baB during cyclophosphamide-induced urinary bladder injury in rat","volume":"48","author":"Tripathi","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0675","doi-asserted-by":"crossref","first-page":"944","DOI":"10.7150\/ijbs.15781","article-title":"Protective effect of thymoquinone against cyclophosphamide-induced hemorrhagic cystitis through inhibiting DNA damage and upregulation of Nrf2 expression","volume":"12","author":"Gore","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0680","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chemosphere.2014.01.038","article-title":"Protective effects of boron on cyclophosphamide induced lipid peroxidation and genotoxicity in rats","volume":"108","author":"Ince","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.lfs.2018.12.018_bb0685","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaim.2017.04.006","article-title":"Mangiferin protects rat myocardial tissue against cyclophosphamide induced cardiotoxicity","volume":"8","author":"Bhatt","year":"2017","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0690","doi-asserted-by":"crossref","first-page":"e00126","DOI":"10.1016\/j.heliyon.2016.e00126","article-title":"Calcium-deficient diet attenuates carbon tetrachloride-induced hepatotoxicity in mice through suppression of lipid peroxidation and inflammatory response","volume":"2","author":"Yoshioka","year":"2016","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2018.12.018_bb0695","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2013.10.024","article-title":"Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells-up regulation of Nrf2 expression and down regulation of NF-\u03baB and COX-2","volume":"1840","author":"Ramyaa","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.lfs.2018.12.018_bb0700","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12013-011-9169-5","article-title":"Acrolein, an environmental toxin, induces cardiomyocyte apoptosis via elevated intracellular calcium and free radicals","volume":"61","author":"Wang","year":"2011","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.lfs.2018.12.018_bb0705","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FJC.0b013e31815bd23d","article-title":"Roles of MAPK and NF-\u03baB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells","volume":"51","author":"Son","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0710","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1084\/jem.20070247","article-title":"HMGB1 release induced by liver ischemia involves toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling","volume":"204","author":"Tsung","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0715","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.intimp.2017.12.019","article-title":"Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4\/NF-\u03baB signaling pathway in mice","volume":"55","author":"Ma","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0720","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejheart.2008.01.004","article-title":"Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice","volume":"10","author":"Riad","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2018.12.018_bb0725","first-page":"75","article-title":"Statins inhibit toll-like receptor-4: a potential role for attenuating doxorubicin-induced cardiomyopathy, biomedicine international (HYPOTHESIS)","volume":"1","author":"Ghavimi","year":"2010","journal-title":"Spring"},{"key":"10.1016\/j.lfs.2018.12.018_bb0730","first-page":"463","article-title":"Astragaloside attenuates cardiotoxicity effects of doxorubicin by inhibiting TLR4\/NF-\u043aB signaling pathway","volume":"2","author":"Nahorski","year":"2014","journal-title":"Am. J. Biomed"},{"key":"10.1016\/j.lfs.2018.12.018_bb0735","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0740","series-title":"Regulation of Ca2+-ATPases, V-ATPases and F-ATPases","first-page":"187","article-title":"Regulation of cardiac sarco (endo) plasmic reticulum calcium-ATPases (SERCA2a) in response to exercise","author":"Hamm","year":"2016"},{"key":"10.1016\/j.lfs.2018.12.018_bb0745","first-page":"C508","article-title":"Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a","volume":"304","author":"Younce","year":"2013","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb0750","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1074\/jbc.M006889200","article-title":"Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation","volume":"276","author":"Sato","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.018_bb0755","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1074\/mcp.M700245-MCP200","article-title":"Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses","volume":"7","author":"Gramolini","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.lfs.2018.12.018_bb0760","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.taap.2012.09.021","article-title":"Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress","volume":"265","author":"Mohammad","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0765","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1096\/fj.03-0724rev","article-title":"The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage","volume":"18","author":"Fogli","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2018.12.018_bb0770","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/BF00418380","article-title":"Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4","volume":"37","author":"Rothe","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2018.12.018_bb0775","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/bjp.2008.6","article-title":"Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat","volume":"153","author":"Andersson","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0780","first-page":"247","article-title":"Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis","volume":"150","author":"Souza-Fiho","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0785","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cbi.2015.02.021","article-title":"Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: role of NF\u03baB\/MAPK pathway","volume":"231","author":"Nafees","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2018.12.018_bb0790","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/359179","article-title":"Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat","volume":"2014","author":"Aronsson","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2018.12.018_bb0795","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1681.2011.05535.x","article-title":"Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice","volume":"38","author":"Jo","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0800","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2005.09.011","article-title":"The ubiquitous role of nitric oxide in cardioprotection","volume":"40","author":"Jones","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0805","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10565-016-9325-1","article-title":"Doxorubicin chemotherapy affects intracellular and interstitial nitric oxide concentrations in skeletal muscle","volume":"32","author":"Fabris","year":"2016","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0810","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/RES.0000000000000110","article-title":"Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association","volume":"119","author":"Griendling","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0815","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.hrthm.2015.01.044","article-title":"Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K\/AKT\/eNOS signaling pathway activation","volume":"12","author":"Chong","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.lfs.2018.12.018_bb0820","doi-asserted-by":"crossref","first-page":"33252","DOI":"10.18632\/oncotarget.16629","article-title":"Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2018.12.018_bb0825","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2169\/internalmedicine.42.82","article-title":"Cyclophosphamide-induced late-onset lung disease","volume":"42","author":"Hamada","year":"2003","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0830","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.yexcr.2008.06.006","article-title":"TGF-\u03b2 coordinately activates TAK1\/MEK\/AKT\/NFkB and SMAD pathways to promote osteoclast survival","volume":"314","author":"Gingery","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb0835","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1139\/cjpp-2015-0138","article-title":"Cardiorenal protective effect of taurine against cyclophosphamide-induced toxicity in albino rats","volume":"94","author":"Alhumaidha","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0840","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40360-017-0184-z","article-title":"Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis","volume":"19","author":"Shaker","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0845","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1002\/jcb.26878","article-title":"The cardioprotective effect of thymoquinone on ischemia-reperfusion injury in isolated rat heart via regulation of apoptosis and autophagy","volume":"119","author":"Xiao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2018.12.018_bb0850","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1570161054368607","article-title":"Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure","volume":"3","author":"Ungvari","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0855","first-page":"H911","article-title":"Dominant-negative p38\u03b1 mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus","volume":"297","author":"Thandavarayan","year":"2009","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb0860","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fphys.2018.00558","article-title":"Loss of akap1 exacerbates pressure overload-induced cardiac hypertrophy and failure","volume":"9","author":"Schiattarella","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0865","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.cdd.4400783","article-title":"Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c","volume":"7","author":"Korsmeyer","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2018.12.018_bb0870","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.lfs.2018.12.018_bb0875","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/onc.2008.297","article-title":"Caspases in apoptosis and beyond","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.12.018_bb0880","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jep.2014.02.019","article-title":"Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under H2O2-induced apoptosis","volume":"153","author":"Park","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0885","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00280-016-3233-1","article-title":"Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitate","volume":"79","author":"El-Agamy","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0890","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1702829","article-title":"Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy","volume":"27","author":"Rosen","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb0895","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.biomaterials.2011.03.048","article-title":"The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis","volume":"32","author":"Ghosh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2018.12.018_bb0900","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2005.03.153","article-title":"Prospective therapeutic applications of p53 inhibitors","volume":"331","author":"Gudkov","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.12.018_bb0905","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00210-017-1437-5","article-title":"All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression","volume":"391","author":"Khafaga","year":"2018","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0910","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/1074248418763612","article-title":"Does p53 inhibition suppress myocardial ischemia-reperfusion injury?","volume":"23","author":"Yano","year":"2018","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.12.018_bb0915","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.93.21.11848","article-title":"Reactive oxygen species are downstream mediators of p53-dependent apoptosis","volume":"93","author":"Johnson","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0920","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1038\/s41598-017-05005-9","article-title":"Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: plausible roles of p53, MAPK and AKT pathways","volume":"7","author":"Mantawy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0925","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/bph.12901","article-title":"p38 MAPK in cardioprotection\u2013are we there yet?","volume":"172","author":"Martin","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0930","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cellsig.2009.11.020","article-title":"Differential activation of p38MAPK isoforms by MKK6 and MKK3","volume":"22","author":"Remy","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2018.12.018_bb0935","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2014.10.042","article-title":"Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway","volume":"746","author":"Shatanawi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0940","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/mmr.2013.1554","article-title":"Activation of the p38 MAPK\/NF-\u03baB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells","volume":"8","author":"Guo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb0945","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/FJC.0b013e318046f34a","article-title":"Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production","volume":"49","author":"Bao","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0950","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2011.02.015","article-title":"Distinct regulation of B-type natriuretic peptide transcription by p38 MAPK isoforms","volume":"338","author":"Koivisto","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0955","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-291X(03)00096-2","article-title":"Disruption of a single copy of the p38\u03b1 MAP kinase gene leads to cardioprotection against ischemia-reperfusion","volume":"302","author":"Otsu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.12.018_bb0960","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.yjmcc.2011.12.009","article-title":"Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress","volume":"52","author":"Wang","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0965","first-page":"3117","article-title":"Protective effect of vitexin reduces sevoflurane-induced neuronal apoptosis through HIF-1\u03b1, VEGF and p38 MAPK signaling pathway in vitro and in newborn rats","volume":"15","author":"Lyu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb0970","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1096\/fj.05-5618fje","article-title":"p38 kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms","volume":"20","author":"Tenhunen","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2018.12.018_bb0975","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.1156037","article-title":"Phosphorylation by p38 MAPK as an alternative pathway for GSK3\u03b2 inactivation","volume":"320","author":"Thornton","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.lfs.2018.12.018_bb0980","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnmol.2011.00045","article-title":"GSK-3 mouse models to study neuronal apoptosis and neurodegeneration","volume":"4","author":"G\u00f3mez-Sintes","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2018.12.018_bb0985","first-page":"8272","article-title":"Inhibition of the NFAT kinases, GSK3beta and Dyrk1a, increases human beta cell proliferation and islet mass","volume":"6","author":"Laffitte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2018.12.018_bb0990","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/jcp.25572","article-title":"Wnt3A induces GSK-3\u03b2 phosphorylation and \u03b2-catenin accumulation through RhoA\/ROCK","volume":"232","author":"Kim","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb0995","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen synthase kinase-3\u03b2: a novel regulator of cardiac hypertrophy and development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1000","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/CIRCRESAHA.109.209643","article-title":"Extracellular heat shock protein 60, cardiac myocytes, and apoptosis","volume":"105","author":"Kim","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11064-017-2426-2","article-title":"Adiponectin attenuates streptozotocin-induced tau hyperphosphorylation and cognitive deficits by rescuing PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"43","author":"Xu","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/labinvest.2016.138","article-title":"Inhibition of infarction-induced sympathetic innervation with endothelin receptor antagonism via a PI3K\/GSK-3\u03b2-dependent pathway","volume":"97","author":"Lee","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2018.12.018_bb1015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3\u03b2 suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb1020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","article-title":"Glycogen synthase kinase-3\u03b2 is a negative regulator of cardiomyocyte hypertrophy","volume":"151","author":"Haq","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-5793(97)01548-2","article-title":"Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin","volume":"421","author":"Welsh","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2018.12.018_bb1030","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI200317295","article-title":"Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling","volume":"111","author":"Braz","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2018.12.018_bb1035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4149\/gpb_2017022","article-title":"Ca2\u00b1dependent calcineurin\/NFAT signaling in \u03b2-adrenergic-induced cardiac hypertrophy","volume":"37","author":"Khalilimeybodi","year":"2018","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.lfs.2018.12.018_bb1040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1045","unstructured":"A. Rao, S. Feske, P. Hogan, Y. Gwack, Regulators of NFAT, in, Google Patents, 2015."},{"key":"10.1016\/j.lfs.2018.12.018_bb1050","doi-asserted-by":"crossref","first-page":"e2004111","DOI":"10.1371\/journal.pbio.2004111","article-title":"Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation","volume":"16","author":"Alam","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1055","series-title":"A Surprising Noncanonical Role for Calcineurin in Pressure-induced Cardiac Hypertrophy","author":"Shaw","year":"2018"},{"key":"10.1016\/j.lfs.2018.12.018_bb1060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fncel.2018.00016","article-title":"Lithium inhibits GSK3\u03b2 and augments GluN2A receptor expression in the prefrontal cortex","volume":"12","author":"Monaco","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2018.12.018_bb1065","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160257","article-title":"Effect of lithium on ventricular remodelling in infarcted rats via the Akt\/mTOR signalling pathways","volume":"37","author":"Lee","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2018.12.018_bb1070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2121-8-27","article-title":"C-Jun N-terminal kinase (JNK) cooperates with Gsk3\u03b2 to regulate Dishevelled-mediated microtubule stability","volume":"8","author":"Ciani","year":"2007","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1075","first-page":"173","article-title":"Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure","volume":"8","author":"Zhang","year":"2003","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1080","first-page":"833","article-title":"Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells","volume":"8","author":"Nikolakaki","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.12.018_bb1085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1095-6433(98)10135-6","article-title":"In vivo prevention of cyclophosphamide-induced Ca2+ dependent damage of rat heart and liver mitochondria by cyclosporin A","volume":"121","author":"Al-Nasser","year":"1998","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1090","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1172\/JCI37873","article-title":"NFAT\/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy","volume":"120","author":"G\u00f3mez-Sintes","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2018.12.018_bb1095","first-page":"7453","article-title":"Hypericin protects against doxorubicin-induced dilated cardiomyopathy in rats via down-regulating expression of Cx43 and inhibiting of TNF-\u03b1, ET-1, BNP","volume":"9","author":"Li","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb1100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.117.311589","article-title":"Physiologic, pathologic, and therapeutic paracrine modulation of cardiac excitation-contraction coupling","volume":"122","author":"Mayourian","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure\u2014a rational approach for disease treatment","volume":"21","author":"Gorski","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2018.12.018_bb1110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2008.07165.x","article-title":"Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation","volume":"142","author":"Tichelli","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","article-title":"Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction","volume":"135","author":"Maeda","year":"1998","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2018.12.018_bb1120","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy564.P920","article-title":"P920 the influence of iron status on the impaired functioning of human cardiofibroblasts and cardiomyocytes in the course of acute phase of myocarditis","volume":"39","author":"Kobak","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2018.12.018_bb1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.12.031","article-title":"Origins of cardiac fibroblasts","volume":"91","author":"Moore-Morris","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2015.07.001","article-title":"Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions","volume":"101","author":"D\u00edaz-Araya","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1135","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2018.12.018_bb1140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/dvdy.20593","article-title":"Transforming growth factor-\u03b2 stimulates epithelial\u2013mesenchymal transformation in the proepicardium","volume":"235","author":"Olivey","year":"2006","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.lfs.2018.12.018_bb1145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.12.018_bb1150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","article-title":"Fibroblasts and myofibroblasts: what are we talking about?","volume":"57","author":"Baum","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molmed.2015.12.006","article-title":"The living scar\u2013cardiac fibroblasts and the injured heart","volume":"22","author":"Rog-Zielinska","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb1160","first-page":"L223","article-title":"Human lung fibroblasts release chemokinetic activity for monocytes constitutively","volume":"275","author":"Koyama","year":"1998","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb1165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MOH.0000000000000424","article-title":"MicroRNAs in endothelial cell homeostasis and vascular disease","volume":"25","author":"Fern\u00e1ndez-Hernando","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2014.09.009","article-title":"Aging and endothelin: determinants of disease","volume":"118","author":"Barton","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.12.018_bb1175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.12.018_bb1180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","article-title":"Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds a statement by the working group on endothelin and endothelial factors of the European Society of Hypertension","volume":"23","author":"Deanfield","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2018.12.018_bb1185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.atherosclerosis.2011.01.001","article-title":"Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice","volume":"215","author":"Srivastava","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2018.12.018_bb1190","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/ATVBAHA.111.227124","article-title":"Acrolein inhalation prevents vascular endothelial growth factor\u2013induced mobilization of Flk-1+\/Sca-1+ cells in mice","volume":"31","author":"Wheat","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14017431.2018.1453942","article-title":"Effects of endothelin-1 on intracellular tetrahydrobiopterin levels in vascular tissue","volume":"52","author":"Cerrato","year":"2018","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.lfs.2018.12.018_bb1200","doi-asserted-by":"crossref","first-page":"e002026","DOI":"10.1161\/CIRCGENETICS.117.002026","article-title":"ET (endothelin)-1 and ischemic heart disease: a Mendelian randomization study","volume":"11","author":"Schooling","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb1205","first-page":"H2295","article-title":"Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation and myocardial remodeling in rats","volume":"287","author":"Murray","year":"2017","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.lfs.2018.12.018_bb1210","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4353462","article-title":"Pentaerythritol tetranitrate in vivo treatment improves oxidative stress and vascular dysfunction by suppression of endothelin-1 signaling in monocrotaline-induced pulmonary hypertension","volume":"2017","author":"Steven","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2018.12.018_bb1215","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.healun.2018.01.579","article-title":"sCD146-a novel marker of systemic venous congestion-positively correlates with plasma endothelin-1-marker of vasoconstriction and inflammation-in heart failure","volume":"37","author":"Colombo","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.lfs.2018.12.018_bb1220","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/352091","article-title":"Protective effect of silymarin against acrolein-induced cardiotoxicity in mice","volume":"2012","author":"Taghiabadi","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2018.12.018_bb1225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2006.09.009","article-title":"Acrolein generation stimulates hypercontraction in isolated human blood vessels","volume":"217","author":"Conklin","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.taap.2009.01.024","article-title":"Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages","volume":"236","author":"O'Toole","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.018_bb1235","doi-asserted-by":"crossref","first-page":"e0123138","DOI":"10.1371\/journal.pone.0123138","article-title":"Acrolein impairs the cholesterol transport functions of high density lipoproteins","volume":"10","author":"Chadwick","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.12.018_bb1240","series-title":"Transplantation Proceedings","first-page":"2670","article-title":"Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice","author":"Zeng","year":"2008"},{"key":"10.1016\/j.lfs.2018.12.018_bb1245","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/S0021-9258(17)39907-6","article-title":"Reversible inhibition of adenine nucleotide translocation by long chain acyl-CoA esters in bovine heart mitochondria and inverted submitochondrial particles. Comparison with atractylate and bongkrekic acid","volume":"252","author":"Chua","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.018_bb1250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2018.12.018_bb1255","first-page":"89","article-title":"Attenuated recovery of contractile function in aging hearts following global ischemia\/reperfusion: role of extracellular HSP27 and TLR4","volume":"189","author":"Ao","year":"2016","journal-title":"Mol. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:18:59Z","timestamp":1758399539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518308014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":251,"alternative-id":["S0024320518308014"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.018","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}